메뉴 건너뛰기




Volumn 173, Issue 7, 2013, Pages 586-588

A national survey of the treatment of hyperlipidemia in primary prevention

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 84876050906     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.2797     Document Type: Note
Times cited : (9)

References (8)
  • 1
    • 77954179995 scopus 로고    scopus 로고
    • Statins and all-cause mortality in highrisk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65, 229 participants
    • Ray KK, Seshasai SR, Erqou S, et al. Statins and all-cause mortality in highrisk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65, 229 participants. Arch Intern Med. 2010;170(12):1024-1031.
    • (2010) Arch Intern Med. , vol.170 , Issue.12 , pp. 1024-1031
    • Ray, K.K.1    Seshasai, S.R.2    Erqou, S.3
  • 2
    • 79952052016 scopus 로고    scopus 로고
    • Statins for the primary prevention of cardiovascular disease
    • Taylor F, Ward K, Moore TH, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011; (1): CD004816.
    • (2011) Cochrane Database Syst Rev. , Issue.1
    • Taylor, F.1    Ward, K.2    Moore, T.H.3
  • 3
    • 74949136266 scopus 로고    scopus 로고
    • Optimizing statin treatment for primary prevention of coronary artery disease
    • Hayward RA, Krumholz HM, Zulman DM, Timbie JW, Vijan S. Optimizing statin treatment for primary prevention of coronary artery disease. Ann Intern Med. 2010;152(2):69-77.
    • (2010) Ann Intern Med. , vol.152 , Issue.2 , pp. 69-77
    • Hayward, R.A.1    Krumholz, H.M.2    Zulman, D.M.3    Timbie, J.W.4    Vijan, S.5
  • 4
    • 67651111687 scopus 로고    scopus 로고
    • Lipid treatment assessment project 2: A multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals
    • Lipid Treatment Assessment Project 2 Investigators
    • Waters DD, Brotons C, Chiang CW, et al; Lipid Treatment Assessment Project 2 Investigators. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation. 2009;120(1):28-34.
    • (2009) Circulation , vol.120 , Issue.1 , pp. 28-34
    • Waters, D.D.1    Brotons, C.2    Chiang, C.W.3
  • 5
    • 13444287861 scopus 로고    scopus 로고
    • National study of physician awareness and adherence to cardiovascular disease prevention guidelines
    • Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111(4):499-510.
    • (2005) Circulation , vol.111 , Issue.4 , pp. 499-510
    • Mosca, L.1    Linfante, A.H.2    Benjamin, E.J.3
  • 6
    • 2342565864 scopus 로고    scopus 로고
    • Drug treatment of hyperlipidemia in women
    • Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA. 2004;291(18):2243-2252.
    • (2004) JAMA , vol.291 , Issue.18 , pp. 2243-2252
    • Walsh, J.M.1    Pignone, M.2
  • 7
    • 4444382862 scopus 로고    scopus 로고
    • Pharmacologic lipidlowering therapy in type 2 diabetes mellitus: Background paper for the American College of Physicians
    • American College of Physicians
    • Vijan S, Hayward RA; American College of Physicians. Pharmacologic lipidlowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med. 2004;140(8):650-658.
    • (2004) Ann Intern Med. , vol.140 , Issue.8 , pp. 650-658
    • Vijan, S.1    Hayward, R.A.2
  • 8
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
    • CARDS investigators
    • Colhoun HM, Betteridge DJ, Durrington PN, et al; CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-696.
    • (2004) Lancet , vol.364 , Issue.9435 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.